These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7723303

  • 1. Validity testing of the accuPINCH THC test.
    Jenkins AJ, Darwin WD, Huestis MA, Cone EJ, Mitchell JM.
    J Anal Toxicol; 1995; 19(1):5-12. PubMed ID: 7723303
    [Abstract] [Full Text] [Related]

  • 2. Validity testing of the EZ-SCREEN cannabinoid test.
    Jenkins AJ, Mills LC, Darwin WD, Huestis MA, Cone EJ, Mitchell JM.
    J Anal Toxicol; 1993 Sep; 17(5):292-8. PubMed ID: 8107464
    [Abstract] [Full Text] [Related]

  • 3. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.
    Huestis MA, Mitchell JM, Cone EJ.
    J Anal Toxicol; 1996 Oct; 20(6):441-52. PubMed ID: 8889681
    [Abstract] [Full Text] [Related]

  • 4. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol: a Delta9-THC-COOH to creatinine ratio study #2.
    Fraser AD, Worth D.
    Forensic Sci Int; 2003 Apr 23; 133(1-2):26-31. PubMed ID: 12742686
    [Abstract] [Full Text] [Related]

  • 5. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana.
    Niedbala RS, Kardos KW, Fritch DF, Kardos S, Fries T, Waga J, Robb J, Cone EJ.
    J Anal Toxicol; 2001 Apr 23; 25(5):289-303. PubMed ID: 11499881
    [Abstract] [Full Text] [Related]

  • 6. Passive cannabis smoke exposure and oral fluid testing.
    Niedbala S, Kardos K, Salamone S, Fritch D, Bronsgeest M, Cone EJ.
    J Anal Toxicol; 2004 Oct 23; 28(7):546-52. PubMed ID: 15516313
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.
    Huestis MA, Henningfield JE, Cone EJ.
    J Anal Toxicol; 1992 Oct 23; 16(5):276-82. PubMed ID: 1338215
    [Abstract] [Full Text] [Related]

  • 10. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol. Study III. A Delta9-THC-COOH to creatinine ratio study.
    Fraser AD, Worth D.
    Forensic Sci Int; 2003 Nov 26; 137(2-3):196-202. PubMed ID: 14609657
    [Abstract] [Full Text] [Related]

  • 11. Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study.
    ElSohly MA, deWit H, Wachtel SR, Feng S, Murphy TP.
    J Anal Toxicol; 2001 Oct 26; 25(7):565-71. PubMed ID: 11599601
    [Abstract] [Full Text] [Related]

  • 12. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
    Manno JE, Manno BR, Kemp PM, Alford DD, Abukhalaf IK, McWilliams ME, Hagaman FN, Fitzgerald MJ.
    J Anal Toxicol; 2001 Oct 26; 25(7):538-49. PubMed ID: 11599597
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis.
    Desrosiers NA, Lee D, Scheidweiler KB, Concheiro-Guisan M, Gorelick DA, Huestis MA.
    Anal Bioanal Chem; 2014 Jan 26; 406(3):785-92. PubMed ID: 24292435
    [Abstract] [Full Text] [Related]

  • 15. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
    Desrosiers NA, Lee D, Concheiro-Guisan M, Scheidweiler KB, Gorelick DA, Huestis MA.
    Clin Chem; 2014 Feb 26; 60(2):361-72. PubMed ID: 24185550
    [Abstract] [Full Text] [Related]

  • 16. Determination of cannabinoids in oral fluid and urine of "light cannabis" consumers: a pilot study.
    Pacifici R, Pichini S, Pellegrini M, Tittarelli R, Pantano F, Mannocchi G, Rotolo MC, Busardò FP.
    Clin Chem Lab Med; 2018 Dec 19; 57(2):238-243. PubMed ID: 30332386
    [Abstract] [Full Text] [Related]

  • 17. Investigation of nitrite adulteration on the immunoassay and GC-MS analysis of cannabinoids in urine specimens.
    Tsai LS, ElSohly MA, Tsai SF, Murphy TP, Twarowska B, Salamone SJ.
    J Anal Toxicol; 2000 Dec 19; 24(8):708-14. PubMed ID: 11110026
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio study.
    Fraser AD, Worth D.
    Ther Drug Monit; 2002 Dec 19; 24(6):746-50. PubMed ID: 12451292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.